Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine - 09/10/21
pages | 12 |
Iconographies | 8 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Coxsackievirus A10 (CVA10) is the main pathogen of hand, foot, and mouth disease in China. However, there are no CVA10-specific drugs and vaccines, and the pathogenesis and effects of this virus in the body are unknown. We investigated the effect of a clinically isolated CVA10 virus strain (CVA10–25) to investigate its effect in suckling mice through different infection routes. We observed the dynamic distribution and proliferation of the virus in mouse tissues by infecting suckling mice with different doses of the virus and mice of different ages with the same dose of the virus. We also analysed the pathological characteristics after infection. A formaldehyde-inactivated experimental vaccine was prepared to immunise 5-week-old BALB/c female mice three times, and newborn suckling mice were tested for the presence of maternally transmitted antibodies. The viral load in each organ after intracerebral administration was higher than that after intraperitoneal administration; the peroral administration route did not cause disease in mice. Mouse paralysis and death after infection were related to age. The skeletal muscles, heart, and lung showed histopathological changes after infection. We established a 2-day-old BALB/c suckling mouse model that could be infected intracranially to study the pathogenesis and pathology of CVA10. Maternally transmitted antibodies protected the mice against the virus. This study provides a reference for CVA10-related pathogenesis and vaccine research.
Le texte complet de cet article est disponible en PDF.Highlights |
• | CVA10-25 was adapted to Vero cells to establish a suckling mouse model. |
• | CVA10 was injected into mice of different ages. |
• | Its dynamic distribution and proliferation varied in the body. |
• | Inactivated vaccine showed a good protective effect against viral infection. |
Abbreviations : CVA10, Vero, RD, HFMD, CVA16, CVA6, EV71, CNS, SPF, RT-PCR, i.c., i.o., i.m., p.o., CCID50, HE, GMT
Keywords : Coxsackievirus 10, Hand, foot, and mouth disease, Proliferation characteristics, Vaccine, Antibody protection
Plan
Vol 143
Article 112212- novembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?